SCHEMBL12875210

SCHEMBL12875210

CNc1c(-c2ccc(OC)c(OC)c2)ncc(-c2ccc(Oc3ccccc3)cc2)c1C(=N)N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCQ Q04759 2/20 0.46
▸ ADORA1 P30542 1/20 0.43
▸ MCL1 Q07820 1/20 0.39
▸ AAK1 Q2M2I8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ RAF1 P04049 1/20 0.37
▸ MAP2K1 Q02750 1/20 0.37
▸ BTK Q06187 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ GAK O14976 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800661 0.87 ADORA1 (0.47) PRKCQADORA1MCL1L3MBTL1BTK
SCHEMBL18800769 0.76 ADORA2A (0.48) ADORA1L3MBTL1BTKALDH1A1HSD17B10
SCHEMBL18800747 0.76 KMT2A (0.46) ADORA1L3MBTL1BTKALDH1A1KDM4E
SCHEMBL18800471 0.75 TNK2 (0.40) PRKCQADORA1L3MBTL1BTKALDH1A1
SCHEMBL18800753 0.73 BTK (0.49) ADORA1BTK
SCHEMBL18800775 0.73 TNK2 (0.48) ADORA1BTKKMT2AMAPTGAA
SCHEMBL18800635 0.72 BTK (0.48) ADORA1BTK
SCHEMBL18800492 0.72 BTK (0.48) ADORA1BTK
SCHEMBL18800651 0.72 BTK (0.43) BTK
SCHEMBL18800616 0.72 BTK (0.47) ADORA1BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011019780-A1 AZAINDAZOLES AS BTK KINASE MODULATORS AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2011-02-17 — — WO disclosed
Send feedback